Original Contributions |
From the Centro de Investigaciones Cardiovasculares, Facultad de Ciencias Médicas, Universidad Nacional de La Plata, La Plata, Argentina.
Correspondence to Dr Horacio E. Cingolani, Centro de Investigaciones Cardiovasculares, Facultad de Ciencias Médicas, Universidad Nacional de La Plata, Calle 60 y 120, 1900 La Plata, Argentina.
| Abstract |
|---|
|
|
|---|
Key Words: Na+-independent Cl--HCO3- exchanger AT1 receptor angiotensin II myocardial pHi protein kinase C
| Introduction |
|---|
|
|
|---|
Ang II is known to regulate myocardial contractility21 and growth.22 The mobilization of Ca2+ and the cardiac hypertrophy occurring under the influence of Ang II stimulation22 23 24 have been shown to involve an activation of the phospholipase C, phospholipase D, and possibly phospholipase A2 pathways.22 25 26 All of these second messenger systems are activated through the AT1 receptor.26 Ang II has been recently shown to increase the activity of two Na+-dependent proton-extruding mechanisms, the NHE17 and the Na+-HCO3- symport, in cardiac muscle.18 19 However, studies on other cells have demonstrated that growth factors (like arginine vasopressin and epidermal growth factor) cause an intracellular acidification in the presence of HCO3- because the stimulatory effect on AE activity is greater than the enhancement of the acid-extruding mechanisms.27 28 In agreement with these observations, we have recently reported that in the presence of the physiological CO2-HCO3- buffer, the positive inotropic effect of Ang II occurs in the absence of any change in pHi.29 The lack of change in myocardial pHi after Ang II in muscles that were exposed to a bicarbonate-containing solution suggested to us that a stimulatory effect on a bicarbonate-dependent acid-loading mechanism was superimposed on the known effect of Ang II on NHE. Therefore, the aim of the present study was to focus on the effect of Ang II on the AE activity in particular and to characterize the nature of the membrane receptor and intracellular signaling pathway through which such an interaction might be mediated.
| Materials and Methods |
|---|
|
|
|---|
2-hour) bubbling of the solution with a gas mixture of
CO2 in O2 to give a final
pH value of 7.40. Cl--free,
Na+-free, low-Ca,2+
HCO3--buffered solution
contained (mmol/L) NMDG 148.0, MgSO4 1.05,
K2SO4 2.25,
CaCO3 0.10, aspartic acid 135.0, and glucose
11.0. All the experiments were performed in the presence of 1.0
µmol/L atenolol (Sigma Chemical Co) plus 1.0 µmol/L prazosin
(Sigma) in order to prevent adrenoceptor activation by the possible
release of catecholamines from nerve endings. Ang II
(Sigma) was added to the superfusate in appropriate amounts to
give a final concentration of 500 nmol/L. NHE activity was inhibited
with EIPA (Research Biochemicals Intl) at 5 µmol/L, whereas SITS
(Sigma) was used at 0.1 mmol/L to inhibit AE mechanisms. SITS was
dissolved in the superfusate immediately before use, and the
solution was protected from light to prevent photodegradation of the
drug. CHE (Research Biochemicals Intl) and calphostin C (Research
Biochemicals Intl) were used at 10 µmol/L and 50 nmol/L,
respectively, as specific inhibitors of
PKC.31 32 Losartan, which was used at
10 µmol/L to block the AT1 receptor
subtype, was a generous gift of Peter K.L. Siegl from Merck Sharp &
Dohme, West Point, Pa. The specific inhibitor of AE
activity, S20787,33 was used at 1 µmol/L
and was a kind donation of Elizabeth Scalbert from the Institut de
Recherches Internationales Servier, Courbevoie, France.
pHi Measurements.
Measurements of pHi in the isolated
muscles were made after loading the muscles with the acetoxymethyl
ester form of the pH-sensitive dye BCECF (BCECF-AM, Molecular Probes)
as previously described.30 BCECF
fluorescence was excited at 450 and 495 nm, and the
fluorescence emission was monitored after passage through a
535±5-nm filter. To limit photobleaching, a neutral-density filter
(1% transmittance) was placed in the excitation light path, and a
manual shutter was used to select sampling intervals (for 3 seconds
every 15 seconds) during the protocol. At the end of each experiment,
fluorescence emission was calibrated by the high
K+nigericin method.34 The
calibration solution contained (mmol/L) KCl 140.0,
MgCl2 1.0, CaCl2 1.0, HEPES
5.0, nigericin 0.01, sodium cyanide 4.0, and 2,3-butanedione monoxime
20.0 (the last to prevent muscle contracture35 ).
Buffer pH was adjusted with KOH to four different values ranging from
7.5 to 6.5. Such a calibration gave a linear relation
(r=.99±.003, n=58) between buffer pH values and the
fluorescence ratio
(F495/F450), with the
latter calculated as follows:
![]() |
The experimental protocols designed for the present study were as follows: basal myocardial pHi was noted after 15 minutes of superfusion with HEPES- or the other HCO-3-buffered solutions indicated above. The muscles were then exposed to Ang II for a further 30 minutes. To study the effect of Ang II on the activity of the AE in its "forward" and "reverse" modes, the muscles were subjected either to intracellular alkaline loads11 13 36 or to the removal of extracellular chloride,16 37 38 respectively.
Intracellular alkalinization was induced by exposing the tissue to TMA
(20.0 mmol/L), a technique that has been already validated for the
study of the activity of the AE.11 36 The
preparations were subjected to two consecutive transient exposures to
TMA. After the first alkaline pulse, the muscles were superfused with
standard HCO3--buffered
solution to allow further recovery of pHi before
the second exposure to TMA (second alkaline pulse). As previously
reported by several investigators, the initial rate of
pHi recovery
(dpHi/dti, in pH unit/min)
was estimated from the slope of the straight lines fitted to the values
of pHi recorded during the first 3 minutes
after the peak of alkalosis by linear least squares regression
analysis.11 13 36 The correlation
coefficient (r) values of the linear fits ranged from .78 to
.96. In control experiments, both TMA pulses occurred under identical
conditions, and no significant difference in the rate of
pHi recovery was detected. When studying the
effect of Ang II, the peptide was included in the superfusate
30 minutes before the second pulse to the end of the experiment.
Intracellular buffering power (ß) was calculated during the alkaline
and acid load of the TMA pulses, in the absence and presence of Ang II,
using the following equation:
![]() |
pHi is the change in
pHi measured immediately after the addition or
withdrawal of TMA and
[TMAH+]i was
calculated on the basis of the rearrangement of the
Henderson-Hasselbach equation:
![]() |
20% increase in ß was detected in the presence of Ang II at each
pHi analyzed. At a mean
pHi of 7.16±0.03, ß values were 58.2±5.9 and
73.2±7.6 mmol/L (n=6, P=NS by paired t
test) in the absence and in the presence of Ang II, respectively,
whereas values of 53.6±20 and 64.6±16 were determined at 7.43±0.04
(n=6, P=NS by paired t test).
After chloride removal from the extracellular space, the activity of
the AE operating in the "reverse" mode was characterized from the
initial rate of the increase in pHi immediately
after Cl- deprivation. The activity
of the Na+-independent AE can be assessed
specifically once Na+ is omitted from the
Cl--free superfusate. Nevertheless, in
order to minimize possible changes in pHi
resulting from the entry of either Ca2+ or
H+ as the result of the reversal of the
Na+-Ca2+ or
Na+-H+ exchangers,
respectively, these experiments were carried out at low
[Ca2+] and in the presence of EIPA. The values
of pHi determined during the removal of
Cl- were fitted to a straight line (by linear
least squares fit of the pHi values recorded
during the first 3 minutes37 ) and also to an
exponential curve of the form
pHit=
pHi
(1-e-k
t),
where
pHit and
pHi
are the changes in pHi from the initial value at
time t and after steady state has been reached, respectively, and
k is the rate constant. Even though the r values
obtained from the fitting to the exponential curve were higher
(r=.86 to .99) than those obtained by linear regression
(r=.61 to .98), the initial rate of the changes in
pHi
(dpHi/dti in pH unit/min)
was determined by both procedures. Although a biexponential probably
fit better than a monoexponential for the entire curve,
the initial rate of the changes in pHi was
essentially the same when estimated either with
monoexponential or biexponential fits. Mean percent
difference between both estimates was 1.25±1.58 (n=28). Two
consecutive Cl--removal protocols were carried
on the same muscle preparation, the first in the absence and the second
in the presence of the specified compounds. The values of
dpHi/dti obtained during
the first and second protocol were then compared. Previous experiments
have shown that dpHi/dti
estimated in two successive Cl--removal
protocols, under control conditions, did not differ from each other.
When the effects of AT1 receptor subtype blockade
or PKC activity inhibition were studied, losartan, CHE, or
calphostin C were, accordingly, added to superfusate 10 minutes
before Ang II. In the experiments with calphostin C, only one
Cl--removal protocol was performed, and the
results obtained were compared with those in the absence of Ang II,
pooling the overall protocols (n=20) under this condition. Neither
losartan nor PKC inhibitors produced significant
changes in resting pHi.
Statistics
Data are expressed as mean±SEM. Statistical analysis of
data was performed by paired t test and ANOVA followed by
Bonferroni's test, as appropriate. Probability of null hypothesis
<5% (P<.05) was considered significant.
| Results |
|---|
|
|
|---|
The steady-state pHi is determined by the balance
between processes that load cells with acid equivalents and those that
extrude them. In the absence of a
CO2-HCO3-
buffer system, the only substantial acid-extruding mechanism is NHE.
Fig 1A
illustrates an experiment in which
a papillary muscle, superfused with a nominal
HCO3--free (HEPES) buffer, was
exposed to 500 nmol/L Ang II. As shown in Fig 1A
, pHi began to increase after 12 minutes of
exposure to the peptide, reaching a value 0.11 U more alkaline than the
initial one after 30 minutes. Fig 1B
shows mean values of basal
pHi and those after 30 minutes of exposure to Ang
II in HEPES-buffered medium (n=4).
|
The results shown in Fig 2
confirm
that the increase in pHi elicited by Ang II in
the absence of HCO3- resulted
from the stimulation of NHE. The blockade of NHE activity by 5
µmol/L EIPA prevented the increase in pHi
induced by Ang II (n=6). Indeed, when the NHE was inhibited in nominal
HCO3--free solution, a slight
but significant decrease in pHi was detected. A
similar decline in pHi after exposure to Ang II
in the absence of NHE activity was previously observed by several
authors and was attributed to a metabolic effect of Ang
II.17 41
|
With HCO3- present in the
superfusate, however, the same dose of Ang II was followed by
no significant changes in myocardial pHi (Fig 3A
). Here, the fact that no significant
increase in pHi could be detected despite the
stimulatory effect of Ang II on the NHE suggested the possibility of a
simultaneous enhancement of a bicarbonate-dependent
acidifying mechanism. The possibility that Ang II depressed the
activity of the
Na+-HCO3-
symport and blunted the increase in pHi is
unlikely, since the cotransporter has been shown to be stimulated by
the peptide.18 19
|
Fig 4
shows the effect of Ang II when
examined in HCO3- buffer after
the blockade of NHE activity with EIPA. A slight transitory decrease in
pHi followed by a return to baseline was detected
in each of the seven experiments. Although these results are difficult
to interpret, a reasonable hypothesis would be that Ang II stimulated
AE activity (thereby decreasing pHi), which was
then followed by a recovery mediated through activation of
Na+-HCO3-
cotransport. The stimulation of symport activity could have been
triggered by the fall in pHi and/or a stimulatory
effect of Ang II on this mechanism.18 19
|
The experiments shown in Fig 5
give
further support to the hypothesis of a stimulatory effect of Ang II on
AE activity. In this series of experiments, the effect of Ang II in
Na+-free
HCO3-buffered medium was
examined. In order to minimize the progressive decrease in
pHi that could result from background acid
loading in the absence of external Na+, the
muscles were exposed to Na+-free solutions only
for a short period (
15 minutes). Under this condition, in which
neither NHE nor the symport was operative, the application of Ang II
resulted in a clear decrease in pHi, indicating
that the peptide stimulated a Na+-independent
HCO3--dependent acidifying
mechanism (Fig 5
). Moreover, this acidifying effect of Ang II in
Na+-free
HCO3-buffered solution was
abolished by pretreatment of the preparations with SITS (average
pHi being 0.008±0.02, n=4). Although the
magnitude of the decrease in pHi was similar to
the one obtained when NHE activity was blocked in HEPES buffer, it
should be considered that in the presence of
HCO3-, the total buffer
capacity is increased, attenuating any change in
pHi for a given acid equivalent flux.
|
The previous results show that in the presence of extracellular
HCO3-, Ang II stimulation of
NHE activity was counteracted by an acidifying mechanism that was SITS
sensitive and independent of external Na+. This
bicarbonate-dependent acid loading was probably mediated by AE
activity. Perhaps the strongest evidence of the stimulatory effect of
Ang II on the AE is apparent in the results shown in Fig 6
. In these experiments, the effect of
Ang II in HCO3--buffered medium
was assessed in the presence of S20787, a recently described specific
inhibitor of AE activity.33 Under
this condition, an increase in pHi was detected
after application of Ang II. The blockade of AE activity seemed,
therefore, to unmask an Ang IIinduced stimulatory effect on the
alkaline loaders and resulted in clearly apparent intracellular
alkalinization. The effectiveness of S20787 as an inhibitor
of AE activity was tested in parallel experiments that proved that
S20787 at 1 µmol/L reduced by 67±12% the rate of
pHi recovery from an intracellular alkaline load
without altering steady-state pHi value (n=3,
data not shown). These results are in agreement with those previously
reported by Lagadic-Gossmann et al.33
|
To further explore the effect of Ang II on AE activity, the following experiments, in which the exchanger was activated while operating in its "forward" and "reverse" modes, were designed.
Action of Ang II on the Activity of the AE After an Intracellular
Alkaline Load
During intracellular alkalosis, a recovery of
pHi resulting from an extrusion of intracellular
HCO3- ions in exchange for
extracellular Cl- can be detected, regardless of
the technique used to increase
pHi.10 11 12 Exposure to TMA
has been previously demonstrated to be a valid technique for
investigating the activity of the AE because no recovery from
TMA-induced intracellular alkalosis is detected in
HCO3--free
solutions.11 42 Papillary muscles were exposed to
TMA, and the velocity of the recovery of pHi was
measured before and after Ang II as an indication of the activity of
the AE. Fig 7
shows the results of one of
six similar experiments. Under control conditions (Fig 7A
),
pHi rose rapidly from a steady-state value of
7.00 to 7.51 after exposing the tissue to TMA. The intracellular
alkalosis was followed by a recovery in pHi due
to the activity of the AE. The rate of pHi
recovery from the intracellular alkaline load was enhanced in the
presence of Ang II (Fig 7B
). On average, in these experiments, exposure
to TMA increased pHi from 7.12±0.04 to
7.49±0.06, and the average rate of pHi recovery
was 0.009±0.003 pH unit/min in the absence of Ang II (n=6). In the
presence of Ang II, TMA caused an elevation in
pHi from 7.12±0.03 to 7.46±0.05, but even
though the alkaline load was of a magnitude similar to that under
control conditions, the velocity of pHi recovery
was increased to 0.018±0.004 pH unit/min (P<.05 by paired
t test), suggesting an enhanced
HCO3- efflux. However, it
should be also considered that the higher rate of recovery could be
merely the result of a decrease in buffering power induced by Ang II.
Buffer capacity was estimated as explained in "Materials and
Methods," and although
20% of increase in ß was detected in the
presence of Ang II, the difference did not reach statistical
significance. Therefore, changes in
dpHi/dti were considered to
be proportional to changes in bicarbonate fluxes.
|
Action of Ang II on the Activity of the AE Operating in the
Reverse Mode
When myocardial tissue is suddenly subjected to the removal of
extracellular Cl-, pHi
rises because of the influx of
HCO3- resulting from the
reversal of AE activity. To measure specifically the activity of this
AE, the removal of Cl- was performed in
Na+-free solutions. Moreover, the
[Ca2+] in this solution had been lowered to
prevent possible pHi shifts resulting from
changes in [Ca2+]i, and
the blockade of NHE was also achieved using EIPA so as to prevent a
possible reversal of the antiporter.11 43 Under
Cl--free conditions, the activity of the AE
could then be estimated from the initial velocity of alkalinization
(dpHi/dti) as used before
by other investigators.37 38 43
Fig 8A
shows the changes in
pHi obtained in a typical experiment after
Cl- removal with a muscle kept in
Na+-free medium for a period longer than an hour,
either in the absence (left) or in the presence of Ang II (right).
Under these experimental conditions, the removal of extracellular
Cl- caused an alkalinization that was readily
reversed on readdition of Cl-. Since
extracellular Na+ was absent in these
experiments, the mechanism that produced this alkalinization must have
been Na+ independent. The theoretical curves
obtained by the exponential fits are shown superimposed to the
pHi tracings in Fig 8A
. Fig 8B
shows the initial
rates of intracellular alkalinization induced by
Cl- removal estimated by these fittings (initial
pHi values were 6.94±0.04 and 6.92±0.03 in the
absence and presence of Ang II, respectively; n=4). Ang II accelerated
the initial rate of alkalinization induced by
Cl- removal in the absence of
Na+. The acceleration induced by Ang II in the
rate of alkalinization was also noted when it was determined by the
fitting of the pHi values recorded after
Cl- removal to a straight line (instead of the
exponential fitting). In this case, the rate of
Cl- removalinduced alkalinization increased
from a control value of 0.011±0.007 to 0.019±0.002 pH unit/min under
Ang II (P<.05 by paired t test).
|
Fig 8C
shows the results from a representative
experiment in which Na+ and
Cl- were simultaneously removed in
order to minimize the induction of intracellular acidosis and a
consequent inactivation of AE.10 38 44 The
theoretical curves obtained by the exponential fits are, like in Fig 8A
, shown superimposed to the pHi tracings. The
average values of the initial rate of alkalinization estimated in the
experiments of this group are illustrated in Fig 8D
. Ang II increased
the initial rate of alkalinization induced by the removal of external
Cl- (baseline pHi was
7.07±0.04 and 7.08±0.04 in the absence and presence of Ang II,
respectively; n=6). The effect of Ang II was also detected when the
initial rate of pHi change was estimated by
fitting the data to a straight line. Mean value was 0.045±0.01 pH
unit/min in the absence of Ang II, and it increased to 0.077±0.02 pH
unit/min in the presence of Ang II (n=6, P<.05 by paired
t test).
Ang II was, then, showing a stimulatory effect on the AE working in reverse mode under rigorous Na+-free conditions and also when Na+ and Cl- deprivation were simultaneously performed. The initial rate of alkalinization, the extent of alkalinization, and the magnitude of the changes induced by Ang II after prolonged Na+ deprivation were, however, only about half of those observed when Na+ deprivation was simultaneous with Cl- withdrawal. This raises the question of whether the increased activity and responsiveness of the AE under less strict Na+ deprivation is due to (1) the presence of residual Na+ stimulating a Na+-dependent Cl--HCO3- exchange or (2) the higher pHi, which stimulates AE activity. This question was addressed by Boyarsky et al38 who showed that in renal mesangial cells the increase in pHi following the removal of Cl- is mediated by the AE, regardless of whether the experiments were carried out in the presence or absence of Na+.38 The authors demonstrated that the reduction in intracellular alkalinization evoked by Cl- removal after Na+ deprivation was only reflecting the inhibition of AE activity by low pHi, as previously reported.10 44 If, in addition, we consider that a Na+-dependent Cl--HCO3- exchange has not been demonstrated in adult cardiac myocytes,8 it is very likely that Na+ deprivation is not necessary to assess AE activity after Cl- removal.
After demonstrating that the activation of AE activity by Ang II could
be detected by Cl- deprivation in
the absence of Na+ and when
Na+ deprivation was
simultaneous with the removal of
Cl-, we used the same protocol as shown in Fig 8C
to assess the subtype of AT receptor involved and the possible role
played by PKC activity. Fig 9A
shows one
of four similar experiments in which losartan (10
µmol/L) was included in the superfusate before testing the
effect of Ang II. The Ang IIinduced increase in the rate of
intracellular alkalinization following Cl-
removal was eliminated when the AT1 receptors
were blocked. The mean values of
dpHi/dti under basal
conditions (no drugs) and in the presence of losartan and Ang
II plus losartan are shown in Fig 9B
. Blockade of
AT1 receptors with losartan did not
change the rate of intracellular alkalinization induced by
Cl- removal and canceled the acceleration
induced by Ang II (Fig 9B
). The suppression by losartan of the
effects of Ang II was also detected when
dpHi/dti values were
determined by linear regression (0.045±0.02 versus 0.044±0.01 pH
unit/min, n=4).
|
In order to gain further insight into the mechanism by which Ang II
enhances the activity of the AE, experiments similar to those described
in Figs 8C
and 9A
were performed but in the presence of the selective
PKC inhibitor, CHE. Fig 10A
presents the results of a representative experiment
in which, like the preceding experiments, the preparations were
subjected to Cl- deprivation first
in the absence of Ang II (left) and then in the presence of Ang II and
CHE (right). Fig 10B
shows the initial rate of changes in
pHi induced by Cl- removal
under control conditions and in the presence of CHE or Ang II plus CHE.
PKC inhibition by CHE decreased the initial rate of alkalinization.
Application of Ang II in the presence of CHE did not significantly
change the initial rate of alkalinization (Fig 10B
) compared with the
control value or with CHE without Ang II (ANOVA). Then, the
acceleration in the initial rate of alkalinization seen with Ang II
alone was no longer detected in the presence of the PKC
inhibitor, either when estimated by linear (0.0395±0.007
versus 0.0330±0.008 pH unit/min, n=4) or exponential fittings (Fig 10B
). A similar suppression of the effects of Ang II on the activity of
the AE was also obtained when another structurally and mechanistically
different inhibitor of PKC activity, calphostin C, was
used. Under this condition, the initial rate of alkalinization
estimated with the exponential fit was 0.0344±0.007 pH unit/min and
with the linear fit was 0.017±0.005 pH unit/min (n=4,
P<.05 compared with Ang II and not significantly different
from control by ANOVA).
|
| Discussion |
|---|
|
|
|---|
Ang II can bind to at least two different types of receptors, referred to as AT1 and AT2.45 The ability of losartan to block the stimulation of the AE would indicate that the effect of Ang II on the AE is mediated by the AT1 receptor subtype. This finding is consistent with recent reports indicating that most of the effects of Ang II on heart muscle involve the participation of AT1 receptors.19 21 22 25 26 Nevertheless, the action of Ang II on Na+-HCO3- cotransport in cultured neonatal rat ventricular myocytes has been found to occur through binding to receptors of the AT2 subtype.18 However, it is important to emphasize that the AT2 receptor subtype is only transiently expressed in the neonatal rat heart.46
AT1 receptors belong to the class of seven transmembrane domain receptors coupled to G regulatory proteins, and their activation by Ang II involves a number of intracellular second messengers. Ang II stimulates phospholipase C, resulting in a subsequent hydrolysis of phosphatidylinositol 4,5-bisphosphate and the formation of inositol 1,4,5-trisphosphate and diacylglycerol. Ang II has also been shown to activate the mitogen-activated protein kinase pathway.47 Therefore, Ang II, like other humoral stimuli known to act through receptors coupled to Gq regulatory proteins, stimulates multiple intracellular phosphotransferase reactions mediated by both PKC-dependent and PKC-independent pathways.24 47 Furthermore, evidence had been presented showing that the NH2-terminal domain of the AE3 protein expressed in brain and heart plays a regulatory role in the activity of the AE,48 and Yannoukakos et al49 noted that the AE3 isoform of cardiac muscle contains several potential PKC consensus phosphorylation sites. Ludt et al50 reported that in Vero cells downregulation of PKC was followed by a change in the sensitivity of the AE to intracellular proton concentration. Our observation that the inhibition of PKC canceled the stimulatory effect of Ang II on the AE activity would further suggest that its action very likely involves a PKC-dependent phosphorylation of the exchanger-protein molecule itself.
Studies on other cells have demonstrated that growth factors (eg, arginine vasopressin and epidermal growth factor) raise pHi by stimulating the NHE. However, in the presence of bicarbonate, growth factors cause an acidification because the stimulatory effect on AE activity is greater than the enhancement of the acid-extrusion mechanisms.27 28 We now show that another growth factor, Ang II, activates the AE of the heart, operating in either the forward or the reverse mode. During the course of the present experiments on cat myocardium, we were aware, by a preliminary communication, that Ang II was shown to have a stimulatory effect on the activity of AE in the perfused ferret heart.51 However, a more recent study by the same authors reported a lack of action of Ang II on the activity of the AE in the same preparation.19
The AE, in addition to mediating the Cl- "shift" in erythrocytes,52 operates as an alkali extruder that regulates pHi in diverse tissues, including lymphocytes,53 smooth muscle cells,54 and myocardium.10 11 16 In cardiac muscle, the AE may be an important mechanism for maintaining [Cl-]i above the level otherwise obtained at electrochemical equilibrium.49 55 Cl- channels, which may also contribute to the regulation of [Cl-]i, have been shown to be activated by Ang II in cardiomyocytes.56
We conclude that Ang II enhances the activity of the AE in ventricular myocardium and that this effect is mediated by the AT1 receptor subtype and involves a PKC-dependent regulatory pathway. The fact that in the presence of bicarbonate no changes in myocardial pHi were detected in our experiments does not argue against an increase in [Na+]i due to stimulation of NHE in the presence of Ang II. The increase in [Na+]i may still be present even if the effects of the increased activity of NHE on pHi were blunted by the enhanced activity of the AE. This [Na+]i increase will lead to a secondary increase in [Ca2+]i through the Na+-Ca2+ exchanger mechanism, and this may contribute to the positive inotropic effect of Ang II. However, the effect of Ang II on the amplitude of Ca2+ transients is controversial,41 57 58 and a synergistic action of [Ca2+]i and pHi in mediating the inotropic effect of Ang II has been proposed.39
A novel acid-loading mechanism has been recently reported.12 This mechanism was proposed to exchange extracellular Cl- for intracellular OH- or, alternatively, to be an H+-Cl- symport. Whether Ang II can activate this novel mechanism through a PKC-dependent pathway was not analyzed by us. However, this possibility seems unlikely if we consider that this novel mechanism is bicarbonate independent.
The Ang IIinduced increase in pHi is not observed in the presence of HCO3- despite suggestions that the rise in pHi may be a growth signal.59 60 It would be advantageous, however, for the activated myocyte to maintain a steady-state pHi within the normal limits but to be able to recover more rapidly from acid and alkali loads. This will be made possible through the simultaneous activation of one alkaline and one acid loader mechanism. The hypothesis that an important physiological effect of the growth factors may be to maintain a near normal pHi while stimulating several acid-base transporters was proposed in 1989 by Boron et al.28 This view was based on experiments studying the effects of arginine vasopressin on renal mesangial cells, and after our findings, it can be extended to the effect of Ang II on myocardium. These findings also emphasize the fact that although HEPES buffer might be a useful experimental tool, conclusions concerning the physiological processes must be drawn from experiments using a CO2-HCO3- buffercontaining saline solution.9
| Selected Abbreviations and Acronyms |
|---|
|
| Acknowledgments |
|---|
Received February 28, 1997; accepted December 19, 1997.
| References |
|---|
|
|
|---|
2.
Fry CH, Poole-Wilson PA. Effect of acid-base changes
on excitation-contraction coupling in guinea-pig and rabbit cardiac
ventricular muscle. J Physiol (Lond). 1981;313:141160.
3. Schaffer SW, Safer B, Ford C, Illingworth J, Williamson JR. Respiratory acidosis and its reversibility in perfused rat heart: regulation of citric acid cycle activity. Am J Physiol. 1978;234(Heart Circ Physiol 3):H40H51.
4. Orchard CH, Kentish JC. Effects of changes of pH on the contractile function of cardiac muscle. Am J Physiol. 1990;258(Cell Physiol 27):C967C981.
5. Kusuoka H, Backx PH, Camilión de Hurtado MC, Azan-Backx M, Marban E, Cingolani HE. Relative roles of intracellular Ca2+ and pH in shaping myocardial contractile response to acute respiratory alkalosis. Am J Physiol. 1993;265(Heart Circ Physiol 34):H1696H1703.
6.
Fabiato A, Fabiato F. Effects of pH on the
myofilaments and the sarcoplasmic reticulum of skinned cells from
cardiac and skeletal muscles. J Physiol (Lond). 1978;276:233255.
7. Lazdunski M, Frelin C, Vigne P. The sodium/hydrogen exchange system in cardiac cells: its biochemical and pharmacological properties and its role in regulating internal concentrations of sodium and internal pH. J Mol Cell Cardiol. 1985;17:10291042.[Medline] [Order article via Infotrieve]
8.
Dart C, Vaughan-Jones RD.
Na+-HCO-3
symport in the sheep cardiac Purkinje fibre. J Physiol
(Lond). 1992;451:365385.
9. Thomas RC. Cell growth factors. Bicarbonate and pHi response. Nature. 1989;337:601.[Medline] [Order article via Infotrieve]
10. Vaughan-Jones RD. Chloride-bicarbonate exchange in sheep cardiac Purkinje fibre. In: Nuccitelli R, Deamer D, eds. Intracellular pH, Its Measurements, Regulation and Utilization in Cellular Functions. New York, NY: Alan R Liss Inc; 1982:239252.
11. Xu P, Spitzer W. Na+-independent Cl--HCO3- exchange mediates recovery of pHi from alkalosis in guinea pig ventricular myocytes. Am J Physiol. 1994;267(Heart Circ Physiol 36):H85H91.
12.
Sun B, Leem CH, Vaughan-Jones RD. Novel
chloride-dependent acid loader in the guinea-pig
ventricular myocyte: part of a dual acid-loading mechanism.
J Physiol (Lond). 1996;495:6582.
13.
Pucéat M, Clément O, Vassort G.
Extracellular MgATP activates the
Cl-/HCO3-
exchanger in single rat cardiac cells. J Physiol
(Lond). 1991;444:241256.
14.
Gambassi G, Spurgeon HA, Lakatta EG, Blank PS,
Capogrossi MC. Different effects of
- and ß-adrenergic
stimulation on cytosolic pH and myofilament responsiveness to
Ca2+ in cardiac myocytes. Circ Res. 1992;71:870882.
15.
Lagadic-Gossmann D, Vaughan-Jones RD. Coupling of dual
acid extrusion in the guinea-pig ventricular myocyte to
1- and ß-adrenoceptor. J Physiol
(Lond). 1993;464:4973.
16.
Désilets M, Pucéat M, Vassort G. Chloride
dependence of pH modulation by ß-adrenergic agonist in rat
cardiomyocytes. Circ Res. 1994;75:862869.
17. Matsui H, Barry WH, Livsey C, Spitzer KW. Angiotensin II stimulates sodium-hydrogen exchange in adult rabbit ventricular myocytes. Cardiovasc Res. 1995;29:215221.[Medline] [Order article via Infotrieve]
18.
Kohout TA, Rogers TB. Angiotensin II
activates
Na+/HCO3-
symport through a phosphoinositide-independent
mechanism in cardiac cells. J Biol Chem. 1995;270:2043220438.
19. Grace AA, Metcalfe JC, Weissberg PL, Bethell HWL, Vanderberg JI. Angiotensin II stimulates sodium-dependent proton extrusion in perfused ferret heart. Am J Physiol. 1996;270(Cell Physiol 39):C1687C1694.
20. Korichneva I, Pucéat M, Millanvoye-Van Brussel E, Géraud G, Vassort G. Aldosterone modulates both the Na/H antiport and Cl/HCO3 exchanger in cultured neonatal rat cardiac cells. J Mol Cell Cardiol. 1995;27:25212528.[Medline] [Order article via Infotrieve]
21. Ishihata A, Endoh M. Pharmacological characteristics of the positive inotropic effect of angiotensin II in the rabbit ventricular myocardium. Br J Pharmacol. 1993;108:9991005.[Medline] [Order article via Infotrieve]
22.
Schunkert H, Sadoshima J, Cornelius T, Kagaya Y,
Weinberg EO, Izumo S, Riegger G, Lorell BH. Angiotensin
IIinduced growth responses in isolated adult rat hearts: evidence for
load-independent induction of cardiac protein synthesis by
angiotensin II. Circ Res. 1995;76:489497.
23.
Berk BC, Aronow MS, Brock TA, Cragoe E, Gimbrone MA,
Alexander RW. Angiotensin II-stimulated
Na+/H+ exchange in cultured
vascular smooth cells: evidence for protein kinase C-dependent and
-independent pathways. J Biol Chem. 1987;262:50575064.
24. Baker KM, Booz GW, Dostal DE. Cardiac action of angiotensin II: role of an intracardiac renin-angiotensin system. Annu Rev Physiol. 1992;54:227241.[Medline] [Order article via Infotrieve]
25.
Sadoshima J, Izumo S. Molecular characterization of
angiotensin IIinduced hypertrophy of cardiac
myocytes and hyperplasia of cardiac fibroblasts: critical role of the
AT1 receptor subtype. Circ Res. 1993;73:413423.
26.
Sadoshima J, Izumo S. Signal transduction pathways of
angiotensin IIinduced c-fos gene expression in
cardiac myocytes in vitro: roles of phospholipid-derived second
messengers. Circ Res. 1993;73:424438.
27. Ganz MB, Boyarsky G, Sterzel RB, Boron WF. Arginine vasopressin enhances pHi regulation in the presence of HCO3- by stimulating three acid-base transport systems. Nature. 1989;337:648651.[Medline] [Order article via Infotrieve]
28. Boron WF, Boyarsky G, Ganz M. Regulation of intracellular pH in renal mesangial cells. Ann N Y Acad Sci. 1989;574:321332.[Medline] [Order article via Infotrieve]
29. Mattiazzi A, Perez NG, Vila-Petroff MG, Alvarez B, Camilión de Hurtado MC, Cingolani HE. Dissociation between the positive inotropic and alkalinizing effects of angiotensin II in feline myocardium. Am J Physiol. 1997;272(Heart Circ Physiol 41):H1131H1136.
30. Camilión de Hurtado MC, Pérez NG, Cingolani HE. An electrogenic sodium-bicarbonate cotransport in the regulation of myocardial intracellular pH. J Mol Cell Cardiol. 1995;27:231242.[Medline] [Order article via Infotrieve]
31. Herbet JM, Augereau JM, Gleye J, Maffrand JP. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun. 1990;172:993997.[Medline] [Order article via Infotrieve]
32. Kobayashi E, Nakano H, Morimoto M, Tamaoki T. Calphostin C, a novel microbial compound, is a highly potent and specific inhibitor of protein kinase C. Biochem Biophys Res Commun. 1989;159:548553.[Medline] [Order article via Infotrieve]
33. Lagadic-Gossmann D, Le Prigent K, Le Baut G, Caignard DH, Renard P, Scalbert E, Feuvray D. Effects of S20787 on pHi-regulating mechanisms in the rat isolated ventricular myocyte. J Cardiovasc Pharmacol. 1996;28:547552.[Medline] [Order article via Infotrieve]
34. Thomas JA, Buchsbaum RN, Zimniak A, Racker E. Intracellular pH measurements in Ehrlich ascites tumor cells utilizing spectroscopic probes generated in situ. Biochemistry. 1979;18:22102218.[Medline] [Order article via Infotrieve]
35. Borzak S, Kelly RA, Kramer BK, Matoba Y, Marsh JD, Reers M. In situ calibration of fura-2 and BCECF fluorescence in adult rat ventricular myocytes. Am J Physiol. 1990;259(Heart Circ Physiol 28):H973H981.
36.
Pérez NG, Alvarez BV, Camilión de Hurtado
MC, Cingolani HE. pHi regulation in
myocardium of the spontaneously hypertensive rat:
compensated enhanced activity of the
Na+-H+ exchanger.
Circ Res. 1995;77:11921200.
37. Jiang L, Stuart-Tilley A, Parkash J, Alper SL. pHi and serum regulate AE2-mediated Cl-/HCO3- exchange in CHOP cells of defined transient transfection status. Am J Physiol. 1994;267(Cell Physiol 36):C845C856.
38. Boyarsky G, Ganz MB, Sterzel RB, Boron WF. pH regulation in single mesangial cells II: Na+-dependent and -independent Cl-/HCO3- exchangers. Am J Physiol. 1988;255(Cell Physiol 24):C857C869.
39. Talukder MAH, Endoh M. Pharmacological differentiation of synergistic contribution of L-type Ca2+ channels and Na+/H+ exchange to the positive inotropic effect of phenylephrine, endothelin-3 and angiotensin II in rabbit ventricular myocardium. Naunyn Schmiedebergs Arch Pharmacol. 1997;355:8796.[Medline] [Order article via Infotrieve]
40.
Yamazaki T, Komuro I, Kudoh S, Zou Y, Shiojima I,
Mizuno T, Takano H, Hiroi Y, Ueki K, Tobe K, Kadowaki T, Nagai R,
Yazaki Y. Angiotensin II partly mediates mechanical
stressinduced cardiac hypertrophy. Circ Res. 1995;77:258265.
41. Ito N, Kagaya Y, Weinberg EO, Barry WH, Lorell BH. Endothelin and angiotensin II stimulation of Na+/H+ exchange is impaired in cardiac hypertrophy. J Clin Invest. 1997;99:125135.[Medline] [Order article via Infotrieve]
42. Wallert MA, Frolich O. Na+/H+ exchange in isolated myocytes from adult rat heart. Am J Physiol. 1989;257(Cell Physiol 26):C207C213.
43.
Korichneva I, Pucéat M, Cassoly R, Vassort G.
Cl-/HCO3-
exchange in developing neonatal rat cardiac cells: biochemical
identification and immunolocalization of band 3like proteins.
Circ Res. 1995;77:556564.
44.
Simchowitz L, Roos A. Regulation of intracellular pH in
human neutrophils. J Gen Physiol. 1985;85:443470.
45.
de Gasparo M, Husain A, Alexander W, Cat KJ, Chiu AT,
Drew M, Goodfriend T, Harding JW, Inagami T, Timmermans PBMWM. Proposed
update of angiotensin receptor nomenclature.
Hypertension. 1995;25:924927.
46. Grady EF, Sechi LA, Griffin CA, Schambelan M, Kalinyak JE. Expression of AT2 receptors in the developing rat fetus. J Clin Invest. 1991;88:921933.
47.
Sadoshima J, Zhihua Q, Morgan JP, Izumo S.
Angiotensin II and other hypertrophic stimuli mediated by G
proteincoupled receptors activate tyrosine kinase,
mitogen-activated protein kinase, and 90-kD S6 kinase in
cardiac myocytes: the critical role of
Ca2+-dependent signaling. Circ Res. 1995;76:115.
48.
Kudrycki KE, Newman PR, Shull GE. cDNA cloning and
tissue distribution of mRNAs for two proteins that are related to band
3
Cl-/HCO3-
exchanger. J Biol Chem. 1990;265:462471.
49.
Yannoukakos D, Stuart-Tilley A, Fernandez HA, Fey P,
Duyk G, Alper SL. Molecular cloning, expression, and chromosomal
localization of two isoforms of the AE3 anion exchanger from human
heart. Circ Res. 1994;75:603614.
50. Ludt J, Tønnessen TI, Sandvig K, Olsnes S. Evidence for involvement of protein kinase C in regulation of intracellular pH by Cl-/HCO3- antiport. J Membr Biol. 1991;119:179186.[Medline] [Order article via Infotrieve]
51. Grace AA, Vanderberg JI. Angiotensin II enhances cardiac pHi regulation in the presence of HCO3- via three acid-base transport mechanisms. Circulation. 1993;88(suppl I):I-331. Abstract.
52. Cabantchik ZA, Knauf PA, Rothstein A. The anion transport system of the red blood cell: the role of membrane protein evaluated by the use of `probes.' Biochim Biophys Acta. 1978;515:239302.[Medline] [Order article via Infotrieve]
53. Grinstein S, Rothstein A, Sarkadi B, Gelfand EW. Responses of lymphocytes to anisotonic media: volume-regulating behavior. Am J Physiol. 1984;246(Cell Physiol 15):C204C215.
54.
Aickin CC, Braidin AF. The role of chloride-bicarbonate
exchange in the regulation of intracellular chloride in guinea-pig vas
deferens. J Physiol (Lond).. 1984;349:587606.
55. Hume JR, Harvey RD. Chloride conductance pathways in heart. Am J Physiol. 1991;261(Cell Physiol 30):C399C412.
56.
Morita H, Kimura J, Endoh M. Angiotensin II
activation of a chloride current in rabbit cardiac myocytes.
J Physiol (Lond). 1995;483:119130.
57.
Ikenouchi I, Barry JH, Bridge JHB, Weinberg EO, Apstein
CS, Lorell BH. Effects of angiotensin II on intracellular
Ca2+ and pH in isolated beating rabbit hearts and
myocytes loaded with the indicator indo-1. J Physiol
(Lond). 1994;480:203215.
58. Fujita S, Endoh M. Effects of endothelin-1 on [Ca2+]i-shortening trajectory and Ca2+ sensitivity in rabbit single ventricular cardiomyocytes loaded with indo-1/AM: comparison with the effects of phenylephrine and angiotensin II. J Card Fail. 1996;2:S45S57.[Medline] [Order article via Infotrieve]
59. Moolenaar WH, Tsien RY, Van deer Saag PT, de Laat SW. Na+/H+ exchange and cytoplasmic pH in the action of growth factors in human fibroblasts. Nature. 1983;304:645648.[Medline] [Order article via Infotrieve]
60.
Rothenberg P, Glaser L, Schlesinger P, Cassel D.
Activation of Na+/H+
exchange by epidermal growth factor elevates intracellular pH in A431
cells. J Biol Chem. 1983;258:1264412653.
This article has been cited by other articles:
![]() |
V. Prasad, I. Bodi, J. W. Meyer, Y. Wang, M. Ashraf, S. J. Engle, T. Doetschman, K. Sisco, M. L. Nieman, M. L. Miller, et al. Impaired Cardiac Contractility in Mice Lacking Both the AE3 Formula Exchanger and the NKCC1 Na+-K+-2Cl- Cotransporter: EFFECTS ON Ca2+ HANDLING AND PROTEIN PHOSPHATASES J. Biol. Chem., November 14, 2008; 283(46): 31303 - 31314. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E. Cingolani and I. L. Ennis Sodium-Hydrogen Exchanger, Cardiac Overload, and Myocardial Hypertrophy Circulation, March 6, 2007; 115(9): 1090 - 1100. [Full Text] [PDF] |
||||
![]() |
H. E. Cingolani, M. C. Villa-Abrille, M. Cornelli, A. Nolly, I. L. Ennis, C. Garciarena, A. M. Suburo, V. Torbidoni, M. V. Correa, M. C. Camilionde Hurtado, et al. The Positive Inotropic Effect of Angiotensin II: Role of Endothelin-1 and Reactive Oxygen Species Hypertension, April 1, 2006; 47(4): 727 - 734. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Palomeque, L. Sapia, R. J. Hajjar, A. Mattiazzi, and M. Vila Petroff Angiotensin II-induced negative inotropy in rat ventricular myocytes: role of reactive oxygen species and p38 MAPK Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H96 - H106. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. V Alvarez, D. M Kieller, A. L Quon, D. Markovich, and J. R Casey Slc26a6: a cardiac chloride-hydroxyl exchanger and predominant chloride-bicarbonate exchanger of the mouse heart J. Physiol., December 15, 2004; 561(3): 721 - 734. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. G Perez, M. C Villa-Abrille, E. A Aiello, R. A Dulce, H. E Cingolani, and M. C Camilion de Hurtado A low dose of angiotensin II increases inotropism through activation of reverse Na+/Ca2+ exchange by endothelin release Cardiovasc Res, December 1, 2003; 60(3): 589 - 597. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E. Cingolani, G. E. Chiappe, I. L. Ennis, P. G. Morgan, B. V. Alvarez, J. R. Casey, R. A. Dulce, N. G. Perez, and M. C. Camilion de Hurtado Influence of Na+-Independent Cl--HCO3- Exchange on the Slow Force Response to Myocardial Stretch Circ. Res., November 28, 2003; 93(11): 1082 - 1088. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E Cingolani, N. G Perez, B. Pieske, D. von Lewinski, and M. C Camilion de Hurtado Stretch-elicited Na+/H+ exchanger activation: the autocrine/paracrine loop and its mechanical counterpart Cardiovasc Res, March 15, 2003; 57(4): 953 - 960. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E. Cingolani and M. C. Camilion de Hurtado Na+-H+ Exchanger Inhibition: A New Antihypertrophic Tool Circ. Res., April 19, 2002; 90(7): 751 - 753. [Full Text] [PDF] |
||||
![]() |
M. C. Camilion de Hurtado, E. L. Portiansky, N. G. Perez, O. R. Rebolledo, and H. E. Cingolani Regression of cardiomyocyte hypertrophy in SHR following chronic inhibition of the Na+/H+ exchanger Cardiovasc Res, March 1, 2002; 53(4): 862 - 868. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Chiappe de Cingolani, P. Morgan, C. Mundina-Weilenmann, J. Casey, J. Fujinaga, M. Camilion de Hurtado, and H. Cingolani Hyperactivity and altered mRNA isoform expression of the Cl-/HCO3- anion-exchanger in the hypertrophied myocardium Cardiovasc Res, July 1, 2001; 51(1): 71 - 79. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. G. Perez, M. C. C. de Hurtado, and H. E. Cingolani Reverse Mode of the Na+-Ca2+ Exchange After Myocardial Stretch : Underlying Mechanism of the Slow Force Response Circ. Res., March 2, 2001; 88(4): 376 - 382. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Papageorgiou, B. E. Shmukler, A. K. Stuart-Tilley, L. Jiang, and S. L. Alper AE anion exchangers in atrial tumor cells Am J Physiol Heart Circ Physiol, March 1, 2001; 280(3): H937 - H945. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G V. Petroff, E. A Aiello, J. Palomeque, M. A Salas, and A. Mattiazzi Subcellular mechanisms of the positive inotropic effect of angiotensin II in cat myocardium J. Physiol., November 15, 2000; 529(1): 189 - 203. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. C. de Hurtado, B. V. Alvarez, I. L. Ennis, and H. E. Cingolani Stimulation of Myocardial Na+-Independent Cl--HCO3- Exchanger by Angiotensin II Is Mediated by Endogenous Endothelin Circ. Res., March 31, 2000; 86(6): 622 - 627. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E. Cingolani Na+/H+ exchange hyperactivity and myocardial hypertrophy: Are they linked phenomena? Cardiovasc Res, December 1, 1999; 44(3): 462 - 467. [Full Text] [PDF] |
||||
![]() |
B. V. Alvarez, N. G. Perez, I. L. Ennis, M. C. Camilion de Hurtado, and H. E. Cingolani Mechanisms Underlying the Increase in Force and Ca2+ Transient That Follow Stretch of Cardiac Muscle : A Possible Explanation of the Anrep Effect Circ. Res., October 15, 1999; 85(8): 716 - 722. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Skolnick, S. E. Litwin, W. H. Barry, and K. W. Spitzer Effect of ANG II on pHi, [Ca2+]i, and contraction in rabbit ventricular myocytes from infarcted hearts Am J Physiol Heart Circ Physiol, November 1, 1998; 275(5): H1788 - H1797. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. E. Cingolani, B. V. Alvarez, I. L. Ennis, and M. C. Camilion de Hurtado Stretch-Induced Alkalinization of Feline Papillary Muscle : An Autocrine-Paracrine System Circ. Res., October 19, 1998; 83(8): 775 - 780. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. V. Alvarez, J. Fujinaga, and J. R. Casey Molecular Basis for Angiotensin II-Induced Increase of Chloride/Bicarbonate Exchange in the Myocardium Circ. Res., December 7, 2001; 89(12): 1246 - 1253. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |